Clinical Trial: Plant-Derived Cannabis Preparation Effective In Children With Autism
Talking Joints Memo
A placebo-controlled clinical trial revealed that twice-daily administration of a standardized plant-derived cannabis extract significantly reduced disease severity and improved anxiety, emotional regulation, and cognition in children with autism spectrum disorder. The treatment demonstrated an excellent safety profile with only mild, non-serious adverse events, while caregivers also reported enhanced family quality of life. These findings support the growing evidence for cannabinoids as a therapeutic option for neurodevelopmental disorders and justify further clinical development of the extract.
All articles from 14 August 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.